Sfoglia per Autore
BRCA1 and anti-angiogenesis: new perspectives on the treatment of non-small-cell lung cancer
2008-01-01 Santarpia, Mariacarmela; Altavilla, Giuseppe; Taron, M.; Rosell, R.
TRANSLATIONAL RESEARCH IN GLIOBLASTOMA MULTIFORME: A REVIEW OF MOLECULAR CRITERIA FOR PATIENT SELECTION
2008-01-01 Rosell, R; DE LAS PEÑAS, R; Balaña, C; Santarpia, Mariacarmela; Salazar, F; DE AGUIRRE, I; Reguart, N; Villa, S; Wei, J; Ramirez, Jl; Molina, Ma; RAMON Y., CAJAL S; Jablons, D; Taron, M.
PIK3CA mutations and BRCA1 expression in breast cancer: potential biomarkers for chemoresistance
2008-01-01 Santarpia, Mariacarmela; Altavilla, Giuseppe; Margeli, M; Cirauqui, B; Mesiti, M; Cavallari, Vittorio; Ramirez, Jl; SANCHEZ RONCO, M; Santarpia, L; Taron, M; Rosell, R.
Erlotinib therapy in a patient with non-small-cell lung cancer and brain metastases
2008-01-01 Altavilla, Giuseppe; Arrigo, C; Santarpia, Mariacarmela; Galletti, G; Picone, G; Marabello, Grazia; Tomasello, C; Pitini, Vincenzo
Liver dysfunction in hcv infected patients with CD20-Positive B-Cell Lymphoma undergoing rituximab combination chemotherapy
2009-01-01 V., Pitini; C., Arrigo; S., Leonardi; Marabello, Grazia; Santarpia, Mariacarmela; G., Lupo; G., Sturniolo; Altavilla, Giuseppe
Amplification and overexpression of the PSMB5 gene contributes to bortezomib resistance in retreatment of patients with multiple myeloma.
2009-01-01 Altavilla, Giuseppe; Arrigo, Carmela; Marabello, Grazia; Galletti, Giuseppe; Santarpia, Mariacarmela; Sauta, Maria Grazia; Pitini, Vincenzo
Novel mutations in the NFkB and NOTCH pathways
2010-01-01 Santarpia, Mariacarmela; Ma, Molina
EML4-ALK fusion gene in lung adenocarcinoma: A retrospective analysis of the outcome of cisplatin plus pemetrexed treated patients.
2010-01-01 Altavilla, Giuseppe; Santarpia, Mariacarmela; C., Arrigo; M., Rizzo; G., Galletti; Marabello, Grazia; Gnani, Alessandro; Pitini, Vincenzo
mRNA levels of genes involved in the nuclear factor кB (NFкB) and Notch signalling pathways in stage IV non-small-cell lung cancer (NSCLC) patients.
2011-01-01 Santarpia, Mariacarmela; C., Costa; V., Pitini; M., Sanchez Ronco; I., Magri; M. A., Molina Vila; M., Taron; R., Rosell; Altavilla, Giuseppe
The nuclear factor кB (NFкB) and Notch signalling pathways and BRCA1 mRNA expression in stage IV non-small-cell lung cancer (NSCLC) patients (p).
2011-01-01 Santarpia, Mariacarmela; M., Sanchez Ronco; I., Magri; M. A., Molina; S., Viteri; C., Costa; A., Gasco; M., Gonzalez Cao; N., Mederos; F., Salazar; J., Bertran Alamillo; A., Jimenez Capitan; Altavilla, Giuseppe; S., Benlloch; Z., Yeste; E., Aldeguer; M., Taron; R., Rosell
Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine.
2011-01-01 Viñolas, N; Provencio, M; Reguart, N; Cardenal, F; Alberola, V; Sánchez Torres, Jm; Barón, Fj; Cobo, M; Maestu, I; Moreno, I; Mesía, C; Izquierdo, A; Felip, E; López Brea, M; Márquez, A; Sánchez Ronco, M; Tarón, M; Santarpia, Mariacarmela; Rosell, R.
Myeloid-derived suppressor cells absolute counts in predicting durable response to R-CHOP in patients with follicular lymphoma.
2011-01-01 Pitini, Vincenzo; Santarpia, Mariacarmela; C., Tomasello; C., Arrigo; Marabello, Grazia; M. G., Sauta; Loddo, Saverio; G., Barresi; Altavilla, Giuseppe
mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients
2011-01-01 Santarpia, Mariacarmela; Ignacio, Magri; Maria Sanchez, Ronco; Carlota, Costa; Miguel Molina, Vila; Ana Gimenez, Capitan; Jordi Bertran, Alamillo; Clara, Mayo; Susana, Benlloch; Santiago, Viteri; Amaya, Gasco; Nuria, Mederos; Enric, Carcereny; Miquel, Taron; Rafael, Rosell
Influence of BRCA1 and astrocyte elevated gene-1 as identified by multiplex target profiling of gene expression on outcome in erlotinib-treated non-small-cell lung cancer patients harboring EGFR mutations.
2011-01-01 M., Taron; S., Benlloch; R., Rosell; J. J., Sanchez; C., Costa; A., Jimenez Capitan; C., Mayo; J., Bertran Alamillo; M. A., Molina; B., Massuti; C., Camps; M., Majem; D., Isla; Santarpia, Mariacarmela; S., Viteri; A., Gasco; T., Moran; E., Carcereny; C., Queralt; I., De Aguirre
The nuclear factor kB (NFkB) and Notch signaling pathways and BRCA1 mRNA expression in stage IV non-small cell lung cancer (NSCLC) patients (p).
2011-01-01 Santarpia, Mariacarmela; M., Sanchez Ronco; I., Magri; S., Viteri; C., Costa; A., Gasco; M., Gonzalez Cao; N., Mederos; F., Salazar; J., Bertran Alamillo; A., Gimenez Capitan; Altavilla, Giuseppe; S., Benlloch; Z., Yeste; E., Aldeguer; M., Taron; R., Rosell
Tyrosine kinase inhibitors for non-small-cell lung cancer: finding patients who will be responsive
2011-01-01 Santarpia, Mariacarmela; Altavilla, Giuseppe; Fernanda, Salazar Maria; Ignacio, Magri; Giuseppe, Pettineo; Benecchi, Sara; Rafael, Rosell
Predicting Response to Chemotherapy With Early-Stage Lung Cancer
2011-01-01 Rafael, Rosell; Miquel, Taron; Bartomeu, Massuti; Nuria, Mederos; Ignacio, Magri; Santarpia, Mariacarmela; Jose Miguel, Sanchez
A friendly approach to pesonalized treatment in lung adenocarcinoma. REVISTA COLOMBIANA DE HEMATOLOGÍA Y ONCOLOGÍA
2012-01-01 R., Rosell; A. F., Cardona Zorrilla; R., Garcia Campelo; M., Majem; E., Carcereny; S., Viteri; A., Gascò; C., Buges; Santarpia, Mariacarmela; J., Wei; B., Massuti; C., Costa; M. A., Molina
EGFR compound mutants and survival on erlotinib in non-small cell lung cancer (NSCLC) patients (p) in the EURTAC study.
2012-01-01 R., Rosell; M. A., Molina Vila; M., Taron; J., Bertran Alamillo; C., Mayo; A., Vergnenegre; F., De Marinis; B., Massuti; J., De Castro; R., Gervais; E., Carcereny; C., Buges; T., Moran; Santarpia, Mariacarmela; E., Felip; M., Majem; J., Bosch; F., Cardenal; A., Drozdowskyj; T. G., Bivona
Lung adenocarcinoma. Molecular-Based Decision Making for Personalized Cancer Management
2012-01-01 R., Rosell; M. L., Botero; T., Bivona; P., Mendez; A. F., Cardona; R., Garcia Campelo; M., Majem; E., Carcereny; S., Viteri; A., Gascó; C., Buges; T., Moran; Santarpia, Mariacarmela; M. A., Molina; L., Romero; F., Salazar; J. L., Ramirez; C., Queralt; J., Bertran Alamillo; I., Chaib; C., Costa; S., Benlloch; A., Vergnenegre; P., Garrido; C., Camps; M., Provencio; J. M., Sanchez; J., de Castro; B., Massuti
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| BRCA1 and anti-angiogenesis: new perspectives on the treatment of non-small-cell lung cancer | 1-gen-2008 | Santarpia, Mariacarmela; Altavilla, Giuseppe; Taron, M.; Rosell, R. | |
| TRANSLATIONAL RESEARCH IN GLIOBLASTOMA MULTIFORME: A REVIEW OF MOLECULAR CRITERIA FOR PATIENT SELECTION | 1-gen-2008 | Rosell, R; DE LAS PEÑAS, R; Balaña, C; Santarpia, Mariacarmela; Salazar, F; DE AGUIRRE, I; Reguart, N; Villa, S; Wei, J; Ramirez, Jl; Molina, Ma; RAMON Y., CAJAL S; Jablons, D; Taron, M. | |
| PIK3CA mutations and BRCA1 expression in breast cancer: potential biomarkers for chemoresistance | 1-gen-2008 | Santarpia, Mariacarmela; Altavilla, Giuseppe; Margeli, M; Cirauqui, B; Mesiti, M; Cavallari, Vittorio; Ramirez, Jl; SANCHEZ RONCO, M; Santarpia, L; Taron, M; Rosell, R. | |
| Erlotinib therapy in a patient with non-small-cell lung cancer and brain metastases | 1-gen-2008 | Altavilla, Giuseppe; Arrigo, C; Santarpia, Mariacarmela; Galletti, G; Picone, G; Marabello, Grazia; Tomasello, C; Pitini, Vincenzo | |
| Liver dysfunction in hcv infected patients with CD20-Positive B-Cell Lymphoma undergoing rituximab combination chemotherapy | 1-gen-2009 | V., Pitini; C., Arrigo; S., Leonardi; Marabello, Grazia; Santarpia, Mariacarmela; G., Lupo; G., Sturniolo; Altavilla, Giuseppe | |
| Amplification and overexpression of the PSMB5 gene contributes to bortezomib resistance in retreatment of patients with multiple myeloma. | 1-gen-2009 | Altavilla, Giuseppe; Arrigo, Carmela; Marabello, Grazia; Galletti, Giuseppe; Santarpia, Mariacarmela; Sauta, Maria Grazia; Pitini, Vincenzo | |
| Novel mutations in the NFkB and NOTCH pathways | 1-gen-2010 | Santarpia, Mariacarmela; Ma, Molina | |
| EML4-ALK fusion gene in lung adenocarcinoma: A retrospective analysis of the outcome of cisplatin plus pemetrexed treated patients. | 1-gen-2010 | Altavilla, Giuseppe; Santarpia, Mariacarmela; C., Arrigo; M., Rizzo; G., Galletti; Marabello, Grazia; Gnani, Alessandro; Pitini, Vincenzo | |
| mRNA levels of genes involved in the nuclear factor кB (NFкB) and Notch signalling pathways in stage IV non-small-cell lung cancer (NSCLC) patients. | 1-gen-2011 | Santarpia, Mariacarmela; C., Costa; V., Pitini; M., Sanchez Ronco; I., Magri; M. A., Molina Vila; M., Taron; R., Rosell; Altavilla, Giuseppe | |
| The nuclear factor кB (NFкB) and Notch signalling pathways and BRCA1 mRNA expression in stage IV non-small-cell lung cancer (NSCLC) patients (p). | 1-gen-2011 | Santarpia, Mariacarmela; M., Sanchez Ronco; I., Magri; M. A., Molina; S., Viteri; C., Costa; A., Gasco; M., Gonzalez Cao; N., Mederos; F., Salazar; J., Bertran Alamillo; A., Jimenez Capitan; Altavilla, Giuseppe; S., Benlloch; Z., Yeste; E., Aldeguer; M., Taron; R., Rosell | |
| Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine. | 1-gen-2011 | Viñolas, N; Provencio, M; Reguart, N; Cardenal, F; Alberola, V; Sánchez Torres, Jm; Barón, Fj; Cobo, M; Maestu, I; Moreno, I; Mesía, C; Izquierdo, A; Felip, E; López Brea, M; Márquez, A; Sánchez Ronco, M; Tarón, M; Santarpia, Mariacarmela; Rosell, R. | |
| Myeloid-derived suppressor cells absolute counts in predicting durable response to R-CHOP in patients with follicular lymphoma. | 1-gen-2011 | Pitini, Vincenzo; Santarpia, Mariacarmela; C., Tomasello; C., Arrigo; Marabello, Grazia; M. G., Sauta; Loddo, Saverio; G., Barresi; Altavilla, Giuseppe | |
| mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients | 1-gen-2011 | Santarpia, Mariacarmela; Ignacio, Magri; Maria Sanchez, Ronco; Carlota, Costa; Miguel Molina, Vila; Ana Gimenez, Capitan; Jordi Bertran, Alamillo; Clara, Mayo; Susana, Benlloch; Santiago, Viteri; Amaya, Gasco; Nuria, Mederos; Enric, Carcereny; Miquel, Taron; Rafael, Rosell | |
| Influence of BRCA1 and astrocyte elevated gene-1 as identified by multiplex target profiling of gene expression on outcome in erlotinib-treated non-small-cell lung cancer patients harboring EGFR mutations. | 1-gen-2011 | M., Taron; S., Benlloch; R., Rosell; J. J., Sanchez; C., Costa; A., Jimenez Capitan; C., Mayo; J., Bertran Alamillo; M. A., Molina; B., Massuti; C., Camps; M., Majem; D., Isla; Santarpia, Mariacarmela; S., Viteri; A., Gasco; T., Moran; E., Carcereny; C., Queralt; I., De Aguirre | |
| The nuclear factor kB (NFkB) and Notch signaling pathways and BRCA1 mRNA expression in stage IV non-small cell lung cancer (NSCLC) patients (p). | 1-gen-2011 | Santarpia, Mariacarmela; M., Sanchez Ronco; I., Magri; S., Viteri; C., Costa; A., Gasco; M., Gonzalez Cao; N., Mederos; F., Salazar; J., Bertran Alamillo; A., Gimenez Capitan; Altavilla, Giuseppe; S., Benlloch; Z., Yeste; E., Aldeguer; M., Taron; R., Rosell | |
| Tyrosine kinase inhibitors for non-small-cell lung cancer: finding patients who will be responsive | 1-gen-2011 | Santarpia, Mariacarmela; Altavilla, Giuseppe; Fernanda, Salazar Maria; Ignacio, Magri; Giuseppe, Pettineo; Benecchi, Sara; Rafael, Rosell | |
| Predicting Response to Chemotherapy With Early-Stage Lung Cancer | 1-gen-2011 | Rafael, Rosell; Miquel, Taron; Bartomeu, Massuti; Nuria, Mederos; Ignacio, Magri; Santarpia, Mariacarmela; Jose Miguel, Sanchez | |
| A friendly approach to pesonalized treatment in lung adenocarcinoma. REVISTA COLOMBIANA DE HEMATOLOGÍA Y ONCOLOGÍA | 1-gen-2012 | R., Rosell; A. F., Cardona Zorrilla; R., Garcia Campelo; M., Majem; E., Carcereny; S., Viteri; A., Gascò; C., Buges; Santarpia, Mariacarmela; J., Wei; B., Massuti; C., Costa; M. A., Molina | |
| EGFR compound mutants and survival on erlotinib in non-small cell lung cancer (NSCLC) patients (p) in the EURTAC study. | 1-gen-2012 | R., Rosell; M. A., Molina Vila; M., Taron; J., Bertran Alamillo; C., Mayo; A., Vergnenegre; F., De Marinis; B., Massuti; J., De Castro; R., Gervais; E., Carcereny; C., Buges; T., Moran; Santarpia, Mariacarmela; E., Felip; M., Majem; J., Bosch; F., Cardenal; A., Drozdowskyj; T. G., Bivona | |
| Lung adenocarcinoma. Molecular-Based Decision Making for Personalized Cancer Management | 1-gen-2012 | R., Rosell; M. L., Botero; T., Bivona; P., Mendez; A. F., Cardona; R., Garcia Campelo; M., Majem; E., Carcereny; S., Viteri; A., Gascó; C., Buges; T., Moran; Santarpia, Mariacarmela; M. A., Molina; L., Romero; F., Salazar; J. L., Ramirez; C., Queralt; J., Bertran Alamillo; I., Chaib; C., Costa; S., Benlloch; A., Vergnenegre; P., Garrido; C., Camps; M., Provencio; J. M., Sanchez; J., de Castro; B., Massuti |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile